Indication
Infantile hypophosphatasia
Infantile hypophosphatasia is a severe, early-onset form of hypophosphatasia, an inherited metabolic disorder caused by loss-of-function variants in the *ALPL* gene that result in deficient tissue-nonspecific alkaline phosphatase activity. Read more about Infantile hypophosphatasia
1 drugs 1 manufacturers
Drugs that treat it
Common Infantile hypophosphatasia therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonInfantile hypophosphatasia is a severe, early-onset form of hypophosphatasia, an inherited metabolic disorder caused by loss-of-function variants in the *ALPL* gene that result in deficient tissue-nonspecific alkaline phosphatase activity.
Typically presenting between birth and six months of age, this systemic condition primarily affects the skeletal, respiratory, and central nervous systems due to impaired bone and dental mineralization.
Hallmarks include progressive rachitic skeletal deformities, flared metaphyses, rib cage instability leading to respiratory compromise, failure to thrive, hypercalcemia, and vitamin B6-dependent seizures.
Biochemically, it is characterized by paradoxically low serum alkaline phosphatase activity accompanied by elevated extracellular substrates such as inorganic pyrophosphate and pyridoxal 5'-phosphate.
- nih.gov
Infantile hypophosphatasia is a severe, early-onset form of hypophosphatasia, an inherited metabolic disorder caused by loss-of-function variants in the *ALPL* gene that result in deficient tissue-nonspecific alkaline phosphatase activity Typically presenting between birth and six months of age, this systemic condition primarily affects the skeletal, respiratory, and central nervous systems due to impaired bone and dental mineralization Biochemically, it is characterized by paradoxically low ser...
- nih.gov
Typically presenting between birth and six months of age, this systemic condition primarily affects the skeletal, respiratory, and central nervous systems due to impaired bone and dental mineralization Biochemically, it is characterized by paradoxically low serum alkaline phosphatase activity accompanied by elevated extracellular substrates such as inorganic pyrophosphate and pyridoxal 5'-phosphate
- nih.gov
Typically presenting between birth and six months of age, this systemic condition primarily affects the skeletal, respiratory, and central nervous systems due to impaired bone and dental mineralization Hallmarks include progressive rachitic skeletal deformities, flared metaphyses, rib cage instability leading to respiratory compromise, failure to thrive, hypercalcemia, and vitamin B6-dependent seizures
- nih.gov
Hallmarks include progressive rachitic skeletal deformities, flared metaphyses, rib cage instability leading to respiratory compromise, failure to thrive, hypercalcemia, and vitamin B6-dependent seizures
Personalize your experience
Follow Infantile hypophosphatasia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.